Theranostic NGS Market

Future Market Insights

Theranostic NGS Market

Key Insight

The theranostic NGS market is projected to grow from USD 2.7 billion in 2025 to USD 5.8 billion by 2035, at a CAGR of 7.8%. Sequencing Instruments & Consumables will dominate with a 39.2% market share, while targeted sequencing panels will lead the technology segment with a 33.2% share.

October 30, 2025

Anurag Sharma

250 Pages

Cite this Report

Theranostic NGS Market

https://www.futuremarketinsights.com/reports/theranostic-ngs-market

License

Buy Now

Summary ToC Companies

Key Players

Agilent Technologies
BGI Genomics Co. Ltd
Guardant Health
Illumina
Oxford Nanopore Technologies
Pacific Biosciences (PacBio)
QIAGEN N.V
Roche Sequencing Solutions
Thermo Fisher Scientific Inc.

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Theranostic NGS Market

Key Players

Similar Industry Reports